Risk for PTSD and Major Depressive Disorder Increased With Mild Traumatic Brain Injury
Some individuals are at a substantially increased risk for mental health problems after mild traumatic brain injury.
PTSD Trauma and Stressor-Related
PTSD
Featured Article
Latest News
FDA Clears Freespira Digital Therapeutic for Post-Traumatic Stress Disorder
Palo Alto Health Sciences announced that the FDA has granted clearance to Freespira, a new digital therapeutic for the treatment of PTSD.
Giving Patients Treatment Choice Improves PTSD Outcomes
Giving patients with post-traumatic stress disorder (PTSD) their preferred treatment improves adherence and symptoms.
In Study of Veterans, Therapy Most Significant Predictor of PTSD Recovery
Patients with PTSD should consider concurrent treatment with evidence-based psychotherapy to maximize their chances for meaningful improvement.
Mindfulness-Based Stress Reduction Effective for Veterans With PTSD
This research supports the use of mindfulness-based stress reduction as a treatment method for veterans with PTSD.
Shame Drives Suicidal Ideation Among Veterans With PTSD
The authors argue that these findings suggest that reducing shame among veterans with post-traumatic stress disorder may reduce the risk for suicide.
Risk Factors for PTSD in Surrogate Decision Makers of Critically Ill Patients
Acting in the capacity of a surrogate decision maker can lead to emotional distress and poor health-related quality of life.
Adolescent Post-traumatic Stress Disorder Symptoms Differ Between Sexes
This initial evidence points toward sex differences among adolescents experiencing PTSD symptoms, both in network connectivity and symptom centrality.
Exposure Therapy Administered by Nonspecialty Healthcare Workers Effective in Treating Adolescent PTSD
Participants in the prolonged exposure therapy arm experienced greater improvements in PTSD symptom severity from baseline to post-treatment than those receiving supportive counseling.
World Trade Center PTSD May Up Risk for Stroke, MI in Clean-Up Crew
World Trade Center-related PTSD is a risk factor for myocardial infarction and stroke among workers involved in cleaning up the debris.
Phase 3 Trial of Potential PTSD Treatment Halted
Participants in the trial were randomized to receive Tonmya 5.6mg sublingually at bedtime for 12 weeks or placebo sublingual tablets.
Want to read more?
Please login or register first to view this content.
Next post in PTSD trauma and stressor-related
